JP2002505660A5 - - Google Patents

Download PDF

Info

Publication number
JP2002505660A5
JP2002505660A5 JP1998513685A JP51368598A JP2002505660A5 JP 2002505660 A5 JP2002505660 A5 JP 2002505660A5 JP 1998513685 A JP1998513685 A JP 1998513685A JP 51368598 A JP51368598 A JP 51368598A JP 2002505660 A5 JP2002505660 A5 JP 2002505660A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP1998513685A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002505660A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1997/015310 external-priority patent/WO1998011073A1/en
Publication of JP2002505660A publication Critical patent/JP2002505660A/ja
Publication of JP2002505660A5 publication Critical patent/JP2002505660A5/ja
Withdrawn legal-status Critical Current

Links

JP51368598A 1996-09-10 1997-09-05 抗ウィルス剤としての8―ヒドロキシ―7―置換キノリン Withdrawn JP2002505660A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US2587096P 1996-09-10 1996-09-10
US5072097P 1997-06-25 1997-06-25
US60/050,720 1997-06-25
US60/025,870 1997-06-25
PCT/US1997/015310 WO1998011073A1 (en) 1996-09-10 1997-09-05 8-hydroxy-7-substituted quinolines as anti-viral agents

Publications (2)

Publication Number Publication Date
JP2002505660A JP2002505660A (ja) 2002-02-19
JP2002505660A5 true JP2002505660A5 (enExample) 2005-05-12

Family

ID=26700264

Family Applications (1)

Application Number Title Priority Date Filing Date
JP51368598A Withdrawn JP2002505660A (ja) 1996-09-10 1997-09-05 抗ウィルス剤としての8―ヒドロキシ―7―置換キノリン

Country Status (6)

Country Link
US (4) US6310211B1 (enExample)
EP (1) EP0927164A1 (enExample)
JP (1) JP2002505660A (enExample)
AU (1) AU4172197A (enExample)
CA (1) CA2262786A1 (enExample)
WO (1) WO1998011073A1 (enExample)

Families Citing this family (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2119155C (en) 1991-10-18 1999-06-15 Dennis Paul Phillion Fungicides for the control of take-all disease of plants
FR2761687B1 (fr) * 1997-04-08 2000-09-15 Centre Nat Rech Scient Derives de quinoleines, possedant notamment des proprietes antivirales, leurs preparations et leurs applications biologiques
US6248739B1 (en) * 1999-01-08 2001-06-19 Pharmacia & Upjohn Company Quinolinecarboxamides as antiviral agents
KR20010102543A (ko) 1999-03-09 2001-11-15 로렌스 티. 마이젠헬더 항바이러스제로서의4-옥소-4,7-디히드로-티에노[2,3-b]피리딘-5-카르복스아미드
TW500724B (en) 1999-10-05 2002-09-01 Pharmacia & Amp Upjohn Company Oxazinoquinolones useful for the treatment of viral infections
CN1416430A (zh) * 2000-03-21 2003-05-07 法玛西雅厄普约翰美国公司 作为抗病毒药的4-氧-1,4-二氢[1,8]-二氮杂萘-3-甲酰胺类
CA2399991A1 (en) 2000-03-21 2001-09-27 Pharmacia & Upjohn Company 4-hydroxy-1,8-naphthyridine-3-carboxamides as antiviral agents
US6562822B2 (en) 2000-07-12 2003-05-13 Pharmacia & Upjohn Company Heterocyle carboxamides as antiviral agents
US6730682B2 (en) * 2000-07-12 2004-05-04 Pharmacia & Upjohn Company Heterocycle carboxamides as antiviral agents
US6559145B2 (en) * 2000-07-12 2003-05-06 Pharmacia & Upjohn Company Heterocycle carboxamides as antiviral agents
AU2001288682A1 (en) 2000-08-30 2002-03-13 Chemocentryx, Inc. Inhibition of cmv infection and dissemination
AU2001287007A1 (en) * 2000-08-30 2002-03-13 Chemocentryx, Inc. Reagents and methods for the diagnosis of cmv dissemination
DE60128936T2 (de) * 2000-10-12 2008-04-10 Merck & Co, Inc. Aza- und polyaza-naphthalenylcarbonsäureamide als hiv-integrase-hemmer
WO2002030931A2 (en) 2000-10-12 2002-04-18 Merck & Co., Inc. Aza- and polyaza-naphthalenyl carboxamides useful as hiv integrase inhibitors
CA2425625A1 (en) * 2000-10-12 2002-07-18 Merck & Co., Inc. Aza-and polyaza-naphthalenyl carboxamides useful as hiv integrase inhibitors
CA2437201C (en) 2001-02-02 2008-11-18 Chemocentryx, Inc. Methods and compositions useful for stimulating an immune response
CZ20032332A3 (cs) * 2001-03-01 2003-11-12 Shionogi & Co., Ltd. Heteroarylové sloučeniny obsahující dusík, které mají inhibiční aktivitu proti HIV integrase
AR036256A1 (es) * 2001-08-17 2004-08-25 Merck & Co Inc Sal sodica de un inhibidor de integrasa del vih, procesos para su preparacion, composiciones farmaceuticas que lo contienen y su uso para la manufactura de un medicamento
WO2003018549A2 (en) 2001-08-30 2003-03-06 Chemocentryx, Inc. Bicyclic compounds as inhibitors of chemokine binding to us28
WO2003020728A1 (en) 2001-08-30 2003-03-13 Pharmacia & Upjohn Company 4-THIOXO-4,7-DIHYDRO-THIENO[2,3-b]PYRIDINE-5-CARBOTHIOAMIDES AS ANTIVIRAL AGENTS
JP2005502685A (ja) 2001-08-30 2005-01-27 ファルマシア・アンド・アップジョン・カンパニー 抗ウイルス剤としての4−チオキソ−4,7−ジヒドロ−チエノ[2,3−b]ピリジン−5−カルボキシアミド
AR038118A1 (es) 2002-01-14 2004-12-29 Upjohn Co Compuestos derivados de la bencinamida del acido 7-oxo-4,7-dihidrotien[2,3-b[piridin-6-carboxilico 3-sustituido que son utiles como antivirales
AR038117A1 (es) 2002-01-14 2004-12-29 Upjohn Co Agentes antivirales derivados de la 4- oxo-4,7 -dihidrofuro [2,3-b]piridin-5-carboxamida
AR038294A1 (es) 2002-01-14 2005-01-12 Upjohn Co Oxotieno(3,2-b)piridincarboxamidas como agentes antivirales
CA2472372C (en) * 2002-01-17 2010-08-17 Melissa Egbertson Hydroxynaphthyridinone carboxamides useful as hiv integrase inhibitors
WO2003077857A2 (en) 2002-03-15 2003-09-25 Merck & Co., Inc. N-(substituted benzyl)-8-hydroxy-1,6-naphthyridine-7- carboxamides useful as hiv integrase inhibitors
US7338956B2 (en) 2002-08-07 2008-03-04 Sanofi-Aventis Deutschland Gmbh Acylamino-substituted heteroaromatic compounds and their use as pharmaceuticals
DE60322920D1 (de) 2002-08-13 2008-09-25 Shionogi & Co Heterocyclische verbindungen mit hiv-integrase-hemmender wirkung
EP1539141B1 (en) * 2002-08-29 2010-07-14 Boehringer Ingelheim Pharmaceuticals Inc. 3-(sulfonamidoethyl)-indole derivatives for use as glucocorticoid mimetics in the treatment of inflammatory, allergic and proliferative diseases
JP2006505571A (ja) * 2002-10-15 2006-02-16 リゲル ファーマシューテイカルズ、インコーポレイテッド 置換されたインドール及びhcv阻害剤としてのその使用
AU2003301439A1 (en) * 2002-10-16 2004-05-04 Gilead Sciences, Inc. Pre-organized tricyclic integrase inhibitor compounds
WO2004056744A1 (en) * 2002-12-23 2004-07-08 Janssen Pharmaceutica N.V. Adamantyl acetamides as hydroxysteroid dehydrogenase inhibitors
DE10306202A1 (de) 2003-02-13 2004-08-26 Grünenthal GmbH Arzneimittel enthaltend substituierte 2-Aryl-Aminoessigsäure-Verbindungen und/oder substituierte 2-Heteroaryl-Aminoessigsäure-Verbindungen
ATE433974T1 (de) * 2003-09-19 2009-07-15 Gilead Sciences Inc Azachinolinolphosphonatverbindungen als integraseinhibitoren
WO2005037859A2 (en) * 2003-10-08 2005-04-28 Massachusetts Institute Of Technology Fluorescence assay for kinase activity
WO2005075475A1 (ja) * 2004-02-04 2005-08-18 Shionogi & Co., Ltd. Hivインテグラーゼ阻害活性を有するナフチリジン誘導体
PL1742642T3 (pl) * 2004-04-14 2009-06-30 Gilead Sciences Inc Analogi fosfonianowe związków inhibitorów integrazy HIV
WO2005108360A1 (en) 2004-05-07 2005-11-17 Janssen Pharmaceutica N.V. Pyrrolidin-2-one and piperidin-2-one derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors
DE602005017159D1 (de) 2004-08-30 2009-11-26 Janssen Pharmaceutica Nv Oxysteroid-dehydrogenase-inhibitoren
JP5137574B2 (ja) 2004-08-30 2013-02-06 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 11−ベータヒドロキシステロイドヒドロゲナーゼ阻害剤としての三環式ラクタム誘導体
JP5208505B2 (ja) 2004-08-30 2013-06-12 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 11−ベータヒドロキシステロイドデヒドロゲナーゼ阻害剤としてのn−2アダマンタニル−2−フェノキシ−アセトアミド誘導体
WO2006043153A2 (en) * 2004-10-20 2006-04-27 Michel Xilinas Use of zinc and copper chelators for the treatment of viral diseases
TW200637539A (en) * 2005-01-20 2006-11-01 Shionogi & Co CTGF inhibitors
AU2006299671A1 (en) * 2005-10-05 2007-04-12 Merck Frosst Canada Ltd Substituted quinolines as inhibitors of leukotriene biosynthesis
RU2009106461A (ru) * 2006-07-25 2010-08-27 Энвиво Фармасьютикалз, Инк. (Us) Хинолиновые производные
US7964729B2 (en) * 2006-08-28 2011-06-21 Massachusetts Institute Of Technology Sox-based kinase sensor
US8440835B2 (en) * 2007-02-26 2013-05-14 Massachusetts Institute Of Technology Environmentally sensitive fluorophores
AU2009271302A1 (en) * 2008-06-24 2010-01-21 Valeant Pharmaceuticals International Benzyloxy anilide derivatives useful as potassium channel modulators
JP2011042643A (ja) * 2009-07-24 2011-03-03 Bayer Cropscience Ag 殺虫性カルボキサミド類
WO2011025546A1 (en) * 2009-08-31 2011-03-03 Massachusetts Institute Of Technology 1, 2, 3-triazole containing protein kinase sensors
EP2345642A1 (en) 2009-12-29 2011-07-20 Polichem S.A. Secondary 8-hydroxyquinoline-7-carboxamide derivatives for use as antifungal agents
EP2345641A1 (en) * 2009-12-29 2011-07-20 Polichem S.A. New secondary 8-hydroxyquinoline-7-carboxamide derivatives
EP2345643A1 (en) * 2009-12-29 2011-07-20 Polichem S.A. New tertiary 8-hydroxyquinoline-7-carboxamide derivatives and uses thereof
US8283366B2 (en) 2010-01-22 2012-10-09 Ambrilia Biopharma, Inc. Derivatives of pyridoxine for inhibiting HIV integrase
WO2012106534A2 (en) * 2011-02-02 2012-08-09 The Regents Of The University Of California Hiv integrase inhibitors
JP2014528412A (ja) * 2011-09-30 2014-10-27 キネタ・インコーポレイテツド 抗ウイルス化合物
CN104334563B (zh) * 2012-05-23 2017-03-08 萨维拉制药有限公司 7‑氧代‑噻唑并吡啶碳酸衍生物和它们在治疗、改善或预防病毒疾病中的用途
AU2013265266A1 (en) * 2012-05-23 2015-01-15 Stemergie Biotechnology Sa Inhibitors of the activity of complex (III) of the mitochondrial electron transport chain and use thereof
CN103709162B (zh) * 2012-09-29 2016-12-07 中国科学院上海药物研究所 三取代咪唑并二氮杂萘酮化合物及其制备方法和用途
WO2016057518A1 (en) * 2014-10-06 2016-04-14 Kineta, Inc. Anti-viral compounds, pharmaceutical compositions, and methods of use thereof
KR102439852B1 (ko) * 2015-04-17 2022-09-05 가천대학교 산학협력단 2-아미노퀴놀린-8-올 유도체, 및 이의 용도
WO2020053654A1 (en) 2018-09-12 2020-03-19 Novartis Ag Antiviral pyridopyrazinedione compounds
CN114667285B (zh) 2019-09-26 2025-08-08 诺华股份有限公司 抗病毒吡唑并吡啶酮化合物
CN111689944B (zh) * 2020-06-10 2021-11-16 中山大学 喹啉色胺杂联体及其在制备治疗阿尔茨海默病的药物中的应用
WO2023041657A1 (en) 2021-09-15 2023-03-23 Katholieke Universiteit Leuven Alkylated haloquinolines for use in epilepsy
EP4166560A1 (en) * 2021-10-13 2023-04-19 Consejo Superior de Investigaciones Cientificas Tri-substituted tetrahydrofurans and use thereof
CN114195736B (zh) * 2021-12-30 2023-08-04 浙江闰土染料有限公司 2-氨基-5-溴-1,3,4-噻二唑的制备方法
WO2024162814A1 (ko) * 2023-02-01 2024-08-08 프라비바이오 주식회사 신규 바이사이클릭 화합물 및 이의 용도

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1908548A1 (de) 1968-02-29 1970-11-05 Warner Lambert Co Chinolinderivate
EP0206751A3 (en) 1985-06-18 1988-05-25 Merck Frosst Canada Inc. 2-substituted quinolines, their preparation and use
JPS63307451A (ja) 1987-06-09 1988-12-15 Konica Corp 粒状性が改良されたハロゲン化銀カラ−写真感光材料
JPH01136152A (ja) 1987-11-21 1989-05-29 Konica Corp ハロゲン化銀カラー写真感光材料
IL89028A0 (en) 1988-01-29 1989-08-15 Lilly Co Eli Quinoline,quinazoline and cinnoline derivatives
IL89029A (en) 1988-01-29 1993-01-31 Lilly Co Eli Fungicidal quinoline and cinnoline derivatives, compositions containing them, and fungicidal methods of using them
DE3804990A1 (de) 1988-02-18 1989-08-31 Basf Ag Herbizid wirksame, heterocyclisch substituierte sulfonamide
JPH02152966A (ja) 1988-12-05 1990-06-12 Otsuka Pharmaceut Co Ltd 4−ヒドロキシカルボスチリル誘導体
JPH0373949A (ja) 1989-05-13 1991-03-28 Konica Corp 熱現像カラー感光材料及び画像形成方法
NZ233752A (en) 1989-05-24 1993-05-26 Merck Frosst Canada Inc Substituted quinoline derivatives, preparation and pharmaceutical compositions thereof
US4959363A (en) * 1989-06-23 1990-09-25 Sterling Drug Inc. Quinolonecarboxamide compounds, their preparation and use as antivirals.
DE69128481T2 (de) 1990-09-07 1998-04-09 Schering Corp Antivirale und antihypertensive verbindungen
CA2091173A1 (en) 1990-09-07 1992-03-08 Adriano Afonso Antiviral compounds and antihypertensive compounds
DE4218308A1 (de) 1992-06-03 1993-12-09 Agfa Gevaert Ag Verfahren zur Herstellung von naphtholischen 2-Äquivalentcyankupplern
JPH0733729A (ja) 1993-07-26 1995-02-03 Kirin Brewery Co Ltd N−シアノ−n′−置換−アリールカルボキシイミダミド化合物の製造法
DK122693D0 (da) 1993-10-29 1993-10-29 Hempels Skibsfarve Fab J C Marin struktur
US5459146A (en) 1993-12-09 1995-10-17 Schering Corporation 4-substituted pyrazoloquinoline derivatives
JPH07165748A (ja) 1993-12-13 1995-06-27 Souyaku Gijutsu Kenkyusho:Kk 複素環ケトン骨格を有する誘導体および抗ウイルス剤
US5506236A (en) 1994-04-28 1996-04-09 Schering Corporation 4-substituted pyrazoloquinoline derivatives
DE4425650A1 (de) 1994-07-20 1996-01-25 Bayer Ag Substituierte Triazolylmethylphenylnaphthyridone
DE4425648A1 (de) 1994-07-20 1996-01-25 Bayer Ag Neue 6 und 6,8-substituierte 1-[4-(1H-1,2,4-triazol-l-yl-methyl)phenyl] Chinoloncarbonsäuren
DE4425659A1 (de) 1994-07-20 1996-01-25 Bayer Ag Neue N1-diverse 6-Fluor-8-difluormethoxy substituierte Chinoloncarbonsäuren
DE4425647A1 (de) 1994-07-20 1996-01-25 Bayer Ag Heterocyclyl-1-phenyl substituierte Chinoloncarbonsäuren
KR960007566A (ko) 1994-08-19 1996-03-22 김정규 신규한 퀴놀릴아민 유도체, 그의 제조방법 및 항부정맥제로서의 용도
JP3713291B2 (ja) 1994-09-30 2005-11-09 富山化学工業株式会社 新規なキノロンまたはナフチリドン化合物もしくはそれらの塩、それらからなる抗ヘルペスウイルス剤
US5681832A (en) 1995-02-17 1997-10-28 The United States Of America As Represented By The Department Of Health And Human Services Aroylaniline compounds, pharmaceutical compositions, and methods of using same to inhibit viral activity
EP0820232A1 (de) 1995-04-08 1998-01-28 Basf Aktiengesellschaft Synergistische fungizide zusammensetzungen aus chinolinderivaten und cytochrom b/c-inhibitors
GB9514265D0 (en) 1995-07-13 1995-09-13 Wellcome Found Hetrocyclic compounds
JP3931386B2 (ja) 1997-07-11 2007-06-13 東レ株式会社 複合加工糸

Similar Documents

Publication Publication Date Title
JP2000502280A5 (enExample)
JP2000501771A5 (enExample)
JP2000501599A5 (enExample)
JP2000501018A5 (enExample)
JP2000500076A5 (enExample)
JP2000501324A5 (enExample)
JP2000500055A5 (enExample)
JP2000500026A5 (enExample)
JP2000502472A5 (enExample)
JP2000501338A5 (enExample)
JP2000501825A5 (enExample)
JP2000500874A5 (enExample)
JP2000502425A5 (enExample)
JP2000502485A5 (enExample)
JP2000502568A5 (enExample)
JP2000501774A5 (enExample)
JP2000500912A5 (enExample)
JP2000501876A5 (enExample)
JP2000501744A5 (enExample)
JP2000501229A5 (enExample)
JP2000502316A5 (enExample)
JP2000500857A5 (enExample)
JP2000502714A5 (enExample)
JP2000500184A5 (enExample)
JP2000501569A5 (enExample)